Bloody Bar 30K Triple Twist E-cigarette Launched in UK with 3 * "2+10" Design

Jan.07.2025
Bloody Bar 30K Triple Twist E-cigarette Launched in UK with 3 * "2+10" Design
UK introduces new Bloody Bar 30K Triple Twist e-cigarette with unique pod design and multiple flavor options.

Special announcement:

This article is for internal industry communication only and does not make any recommendations for brands or products.

The images presented in this article are for descriptive purposes only and are not intended as advertisements for any products.

This article is prohibited for minors to access.


 

UK e-cigarette market have launched a new e-cigarette - the Bloody Bar 30K Triple Twist. This product features a unique design that combines 3 "2+10" combinations, offering triple flavors and 30,000 puffs.

 

Bloody Bar 30K Triple Twist E-cigarette Launched in UK with 3 *
Translation: Bloody Bar 30K Triple Twist|Image source: goldenvape

 

 

Specifically, the product specifications of the Bloody Bar 30K Triple Twist are as shown in the table below.

Bloody Bar 30K Triple Twist E-cigarette Launched in UK with 3 *
Bloody Bar 30K Triple Twist Parameters | Design: 2Firsts

The key feature of the Bloody Bar 30K Triple Twist is its unique pod design. This e-cigarette device comes with three "2+10" pods, each with a total e-liquid capacity of 36 milliliters. Additionally, each pod can be filled with a different e-liquid flavor, allowing for quick flavor changes through a rotating mechanism.

 

Previously, Bloody Bar released a 2-in-1 e-cigarette called the Bloody Bar Ultra Twist 20K, which is capable of providing two different flavors at the same time. Users can easily switch between flavors by rotating the mouthpiece.

 

Bloody Bar 30K Triple Twist E-cigarette Launched in UK with 3 *
Public Notice | Image Source: MHRA

 

It is worth noting that the UK's Medicines and Healthcare products Regulatory Agency (MHRA) e-cigarette notification system shows that "BLOODY BAR TRIPLE TWIST 30K" was publicly announced in November 2024. The applicant is BOWMAN SPECIALISED LIQUIDS LIMITED, founded by Christopher Bowman in 2012, a company focused on research and sales of e-cigarette e-liquids.

 

Bloody Bar 30K Triple Twist E-cigarette Launched in UK with 3 *
BOWMAN SPECIALISED LIQUIDS LIMITED Website | Image source: BOWMAN

 

Currently, the Bloody Bar 30K Triple Twist has been listed on various UK e-cigarette distributor websites such as vapesourcing, ecigone, and vapeuk, with a price of approximately £12.99. However, the product has not yet been made available for sale on the company's official website.

 

Bloody Bar 30K Triple Twist E-cigarette Launched in UK with 3 *
Blood Bar 30K Triple Twist | Image source: vapesourcing

 


2Firsts will continue to monitor the performance and market trends of e-cigarette products globally, providing accurate and authoritative industry information to the public.

 

2FIRSTS, a product column, is dedicated to providing readers with the latest information on new products in the tobacco industry. To gather and share first-hand industry information more widely, 2FIRSTS welcomes readers to submit articles and share the latest products in the e-cigarette field with us.

 

If you have any unique insights or information, please feel free to contact us anytime via email at info@2firsts.com.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

China’s HTP Exports Fell 14.3% in H1 2026 as Russia and Belarus Accounted for 76% Lead
China’s HTP Exports Fell 14.3% in H1 2026 as Russia and Belarus Accounted for 76% Lead
In H1 2026, China’s HS 24041100 exports stood at $1.32 million, down 14.3% YoY, with volume falling 17.2% to 55.33 tons. Market distribution shifted drastically amid overall export drops. Exports to Russia and Belarus totaled $1 million, taking 76.0% of all shipments versus 29.5% in H1 2025. Belarus became the top destination with export value jumping 177.5%, while the Philippines, Singapore and Indonesia’s combined share slumped from 49.3% to 11.2%.Domestically, Yunnan led exporter registrations; Jiangsu and Shanghai were key suppliers, yet Anhui and Sichuan had no exports. Heavy concentration means order or declaration changes for Russia/Belarus greatly affect national aggregate data. The data shows customs entry points (not end markets), covering tobacco consumables only, excluding heating equipment and the complete HTP supply chain.
Aug.11
Florida Governor DeSantis Expands TANF Restrictions, Blocking Welfare Benefits From Buying Tobacco and Vapes
Florida Governor DeSantis Expands TANF Restrictions, Blocking Welfare Benefits From Buying Tobacco and Vapes
Florida Governor Ron DeSantis announced an expansion of Temporary Assistance for Needy Families (TANF) restrictions that would prohibit Electronic Benefit Transfer (EBT) funds from being used to purchase tobacco and vaping products. The state will amend its TANF State Plan and submit the changes for federal approval. Florida officials said the restrictions would not affect eligibility for temporary cash assistance or the amount of benefits received, but would change how funds can be spent.
Aug.25
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
At the 2026 New Approaches Summit in New York, FDA Center for Tobacco Products Director Bret Koplow said the PMTA pathway is “predicated on tobacco harm reduction.” He outlined four CTP priorities: youth prevention, helping adults quit or switch to lower-risk products, improving relative-risk communication, and reducing unauthorized products. Koplow also addressed flavored e-cigarettes, public risk perceptions, industry credibility and efforts to make PMTA reviews more efficient and predictable.
Sep.26
Canada Considers Easing Pharmacy-Only Nicotine Pouch Sales Rules, Potentially Reopening Convenience Store Channel
Canada Considers Easing Pharmacy-Only Nicotine Pouch Sales Rules, Potentially Reopening Convenience Store Channel
Canada's federal government is considering changes to current restrictions on where nicotine pouches can be sold, potentially allowing authorized products to return to convenience stores and other general retail channels, although no decision has been made. Since 2024, emerging nicotine replacement therapy products such as nicotine pouches have been largely restricted to behind-the-counter pharmacy sales. Health Canada, meanwhile, continues to recall unauthorized and higher-strength nicotine pouches, indicating that the current discussion concerns retail access for authorized products rather than a broad relaxation of nicotine pouch regulation.
Sep.14
Australia-China Operation Dismantles Tobacco Smuggling Network: 112 Containers, 60 Arrests and A$92 Million in Illicit Tobacco
Australia-China Operation Dismantles Tobacco Smuggling Network: 112 Containers, 60 Arrests and A$92 Million in Illicit Tobacco
According to The Maritime Executive on August 19, 2026, the Australian Border Force (ABF) and China’s Anti-Smuggling Bureau of General Administration of China Customs worked together to dismantle an international illicit tobacco smuggling network targeting Australia. According to information released by ABF on August 20, sustained information sharing and cooperation led to investigations into 112 shipping containers, with 91 found to contain illicit tobacco. Authorities seized more than 60 million cigarettes and 60 kilograms of loose-leaf tobacco, representing more than A$92 million in unpaid duties. More than 60 people suspected of involvement in the network were arrested in China.
Aug.20
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
Philip Morris International is expanding its U.S. ZYN nicotine pouch portfolio with new 1.5 mg and 8 mg strengths and plans to move its core 3 mg and 6 mg dry-pouch products from 15 to 20 pouches per can in the fourth quarter of 2026. ZYN ULTRA is also commercially available, with FDA authorization covering 10 products at 9 mg and one 11 mg Smooth product. PMI U.S. lists the new 1.5 mg and 8 mg strengths as commercially available, but as of September 10 they do not appear on the FDA’s public authorization list. Public materials do not identify which PMTA submissions cover the two new strengths or their current review status.
Sep.11